Bindu Kalesan, MPH, PhD, is a clinical epidemiologist and a biostatistician. Dr. Kalesan is interested in clinical and health outcomes research. Her work primarily explores cardiovascular and other long-term consequences in patients undergoing treatment for cardiac diseases, cancer, infectious diseases and trauma. She also focuses on public health consequences of firearm violence in the US and the short- and long- term effects of firearm injury survivorship.
Currently she is a faculty and the Director of TEC, department of Medicine at Boston University School of Medicine and works on clinical trials, longitudinal studies and meta-analyses in cardiovascular, diabetes, oncology, infectious diseases and injury/safety research areas. Prior to joining BUSM, she held positions at Columbia University and PPDI. At Columbia University, Dr. Kalesan held the position of Assistant Professor of Surgery and Epidemiology and worked with clinician researchers to provide methodological and statistical support along with developing her independent research of gun violence. At PPDI, she was the Associate Director of Epidemiology and Real World Outcomes and worked with multiple pharmaceutical collaborators as epidemiologist in clinical trials, cohort studies and evidence synthesis.
Dr. Kalesan received her PhD in clinical epidemiology and biostatistics from University of Bern, master’s degree in public health and another in epidemiology from the Johns Hopkins Bloomberg School of Public Health and Christian Medical College, India.